Freshly squeezed vaccines
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.
Cancer biologist and Koch Institute director recognized with MIT faculty’s top honor.
Bhatia is recognized for her work in tissue engineering, disease detection, and advocacy for women in STEM.
Model from MIT's Computer Science and Artificial Intelligence Laboratory aims to automatically distinguish lymphoma subtypes.
Implantable device could allow doctors to test cancer drugs in patients before prescribing chemotherapy.
Stimulating both major branches of the immune system halts tumor growth more effectively.
Discovery could offer a new target for treatment of glioblastoma.
Acoustic device can rapidly isolate circulating tumor cells from patient blood samples.
MIT team finds mechanism by which exposure to vinyl chloride may produce cancerous mutations.
Graduate student Steven Keating takes a problem-solving approach to his brain cancer.
Researchers find a 10 percent annual increase, after inflation.
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
Daniel Anderson wants to bring advances in drug delivery and biomaterials to the clinic.
Senior Yiping Xing’s view of health care draws upon research, public health, and policy.
Newly tenured biological engineer Ernest Fraenkel goes where the numbers lead.